🌟Honored to spotlight Prof. Gerhard Kostner, Editor-in-Chief of ALR and a leading authority on Lp(a), lipoprotein metabolism, and atherosclerosis. His pioneering work drives cardiovascular science forward. Contact: [email protected] More:sciexplor.com/alr/editorial_…

☀️Latest Short Communication！ A new pilot study shows that Lp(a) testing in severe PAD patients is both feasible and highly revealing—uncovering significant rates of elevated Lp(a) tied to worse limb ischaemia. More:sciexplor.com/articles/alr.2… #LipoproteinA #PAD

👉Honored to highlight Prof. Gerd Utermann, ALR Honorary Editor and a pioneer in human genetics and Lp(a) research. His seminal work on apoE and apo(a) polymorphisms continues to shape our understanding of cardiovascular disease and genetic risk. More:sciexplor.com/alr/editorial_…

👉Meet Michael B. Boffa from UWO! Expert in Lp(a), thrombosis, fibrinolysis & cardiovascular disease, bridging protein biochemistry with clinical impact. More：sciexplor.com/alr/editorial_… #CardioResearch #LipoproteinA #Thrombosis

Just published in ALR! 📢 Elevated Lp(a) is common and strongly tied to PAD severity. This pilot highlights how the LILAC-for-Lp(a) pathway can transform inpatient detection and management. A promising step toward better care.🌟 More:sciexplor.com/articles/alr.2… #PAD #LILAC

Our ALR Youth Editorial Board member @PabloCorralMD has a new publication out! 📢 In a 3,000-patient registry, 31% had elevated Lp(a) — linked to higher rates of CAD, PAD & major CV events. Read the full article here 👇 atherosclerosis-journal.com/article/S0021-… #LipoproteinA #CVD

We’re excited to welcome Dr. Maya S. Safarova (Maya S Safarova, MD, PhD) to the ALR Youth Editorial Board! 🎉 Her work in cardiovascular prevention, women’s health, lipid disorders, and vascular aging strengthens ALR’s mission.🌟 More:sciexplor.com/alr/youth_edit… #LipoproteinA #PrecisionMedicine

🎉 Welcome Dr. Pablo Corral (Pablo Corral MD)to the ALR Youth Editorial Board! With expertise in lipids, cardiovascular prevention, and genetic dyslipidemias, he will help advance cutting-edge research in ALR.💡 More:sciexplor.com/alr/youth_edit… #LipoproteinaA #Cardiology

🎉Welcome Dr. Kevin Chemello (Kevin Chemello ) to the ALR Youth Editorial Board! His work focuses on Lipoprotein(a), lipoprotein metabolism, and diabetes. We look forward to his contributions to ALR. 🌟 More:sciexplor.com/alr/youth_edit… #LipoproteinA #Diabetes

🚨 Did you know? Over 20% of hospitalized PAD patients have severely elevated Lipoprotein(a) — yet it’s often overlooked. Using the LILAC-for-Lp(a) pathway, testing rates skyrocketed in just 3 months ! More:sciexplor.com/articles/alr.2… #vascularhealth #PAD

🎉 We are thrilled to welcome Dr. Alpo Vuorio (CARDIOVASCULAR PUBLIC HEALTH) to the ALR Youth Editorial Board! His expertise spans Lipoprotein(a), genetic dyslipidemias, and preventive cardiology. Excited for his contributions! 🌟 More:sciexplor.com/alr/youth_edit… #LipoproteinA #Cardiology

New Perspective📢 🖊️ Alpo Vuorio, Petri T. Kovanen, Bruce Budowle, Frederick J. Raal 🌟 Lp(a) links infections (from SARS-CoV-2 to HIV) to atherosclerosis, extending the impact of Lp(a)-lowering therapies beyond CV risk. More:sciexplor.com/articles/alr.2… #LipoproteinA #Infection

🎄 Merry Christmas from Advances in Lipoprotein(a) Research !✨ #MerryChristmas #ALR #LipoproteinA

Welcome to read the most popular article published in ALR. Click the link for more information. “Lipoprotein(a) and its role in cardiovascular disease: focus on PAD, limb events, AAA, and inflammation” sciexplor.com/articles/alr.2… #Lipoprotein(a)#cardiovascular #PAD

Advances in Lipoprotein(a) Research (ALR) is seeking outstanding experts in the Lp(a) research field to join our Editorial Board and Young Editorial Board. Click the link below for more details. sciexplor.com/alr #Lpa #Journal #Editorialboard

Latest research on #Lipoprotein(a) out now in ALR! Dive into cutting-edge insights & clinical advances here 👉 sciexplor.com/articles/alr.2… #Lpa #biosynthesis #assembly #diagnostic #therapy #OpenAccess #NoAPC

What’s the role of Lp(a) in ischemic stroke subtypes? 🔍 The paper from sheds light: high Lp(a), %APOB in Lp(a), and OxPL-APO(a) are associated with atherosclerotic stroke, particularly ECAD. Check out the findings: sciexplor.com/articles/alr.2… #Lpa #StrokeResearch

Is one lifetime Lp(a) measurement enough? Emerging evidence shows meaningful variability, challenging the "one-and-done" approach. sciexplor.com/articles/alr.2… #Lpa #Cardiology

🙌We are pleased to share our latest publication: 👉 Is it time to rethink the single lifetime measurement of Lipoprotein(a)? For decades, Lp(a) has been considered a genetically determined and largely stable biomarker—supporting the recommendation of a single lifetime

Warmly welcome Dr. Alexander C. Razavi join us! sciexplor.com/alr/youth_edit… ALR continues to warmly welcome all the outstanding experts and scholars in the field of Lp(a) research! sciexplor.com/alr/editorial_… #Editorialboard #Lpa #member